| Similar Articles |
|---|
 |
BusinessWeek
July 18, 2005
Moon Ihlwan |
Stem Cell Sleuth Seoul is funding Hwang Woo Suk in a bid to turn Korea into a global research hub for stem cell research.   |
| AskMen.com |
Cloning Expert Jailed A South Korean stem cell scientist once hailed as a hero for bringing hope to people with incurable diseases and creating the world's first cloned dog was convicted Monday on criminal charges related to faked research, but avoided jail. |
Scientific American
March 2006 |
Con Men in Lab Coats Five decades after it was revealed as a forgery, the Piltdown man still haunts paleoanthropology. Now, thanks to the disgraced stem cell researcher Woo Suk Hwang, cell biology has a high-profile scandal of its own to live down. |
BusinessWeek
July 18, 2005 |
Research and "False Expectations" While Korean scientist Hwang Woo Suk is eager to see practical applications of his work, he warns that optimism needs to be qualified by reality. |
Bio-IT World
August 2005
Maureen McDonough |
U.K. Framework Offers Stem Cells a Future The United Kingdom has managed to cut through the noise surrounding stem cell research, creating a regulatory framework that fosters an environment of international collaboration and excellent R&D programs. And they try to do it all in an ethical way. |
BusinessWeek
January 10, 2005
Bruce Einhorn |
Asia Is Stem Cell Central Singapore isn't the only country in the region trying to profit from the U.S. restrictions. Australia, China, India, Japan, and South Korea all see stem cell research as a way to get ahead in biotech. |
BusinessWeek
January 23, 2006
Arlene Weintraub |
A "Body Blow" To Stem Cell Research Funding for stem cell research in the U.S. wasn't so hot even before the Korean scandal broke. |
Bio-IT World
October 14, 2004 |
Stem Cells and the Ballot Box Science policy is seldom a pivotal factor in U.S. presidential elections, but this year might be an exception. |
Bio-IT World
April 16, 2004
Kevin Davies |
A Black Eye for Bioethics Elizabeth Blackburn, an internationally renowned cell biologist, received a surprise phone call from the White House, informing her that her services on the President's Council on Bioethics would no longer be required. |
Wired
January 2004
Wendy Goldman Rohm |
Seven Days of Creation The inside story of a human cloning experiment |
Bio-IT World
Dec 2005/Jan 2006
Maureen McDonough |
The Century of the Cell Like most new life science industries, the stem cell business landscape looks like a maze. There are many paths, turns, and dead-ends, but it is quite possible that there will be more than one route to the finish line. |
Pharmaceutical Executive
October 1, 2012
Ben Comer |
Stem Cells: A Promise Deferred? Ideology, politics, and a stilted political debate may be causing pharma to overlook the potential of emerging stem cell therapies in fostering a new generation of cures. |
The Motley Fool
December 1, 2008
Brian Orelli |
Obama Can't Save Stem Cell Companies While government-sponsored research on embryonic stem cells might eventually help scientists better understand all stem cells, it's not likely to help the companies right now. |
Scientific American
July 2008
Sally Lehrman |
Dolly's Creator Moves Away from Cloning and Embryonic Stem Cells Like many stem cell pioneers, Ian Wilmut, the creator of Dolly the sheep, has jumped to an alternative approach. Is this the beginning of the end for embryonic cloning? |
Reason
October 2001
Ronald Bailey |
Blastocyst Brouhaha Which human cells count as people? |
Wired
June 2005
Clive Thompson |
How to Farm Stem Cells Without Losing Your Soul A solution to the stem cell dilemma that even the Vatican can love. |
The Motley Fool
May 2, 2011
Brian Orelli |
StemCells Up for All the Right Reasons Federal funding doesn't matter for most stem cell companies. |
Wired
January 2003
Charles C. Mann |
The First Cloning Superpower Inside China's race to become the clone capital of the world. |
BusinessWeek
June 13, 2005
Arlene Weintraub |
A Boost for Broken Hearts? The Institute of Regenerative Medicine in Barbados is convinced that stem cells from fetuses can repair cardiac damage. |
Salon.com
December 29, 2000
Arthur Allen |
Will Thompson, Bush clash over human embryo research? The HHS nominee supports it, but right-to-lifers want it stopped.... |
The Motley Fool
September 29, 2010
Brian Orelli |
Careful What You Wish For, Stem Cell Investors Investors seem to have forgotten about fundamentals. |
| AskMen.com |
Synthetic Sperm Created British scientists claimed Wednesday to have created human sperm from stem cells, but other experts questioned their data. |
The Motley Fool
February 2, 2005
Rich Duprey |
Aastrom to Leap Into Trials The biotech firm advances to the next stage of clinical studies in stem cell research. Investors, take note. |
The Motley Fool
December 22, 2009
Brian Orelli |
Pfizer Swings for the Fences A long shot, but at least it's cheap. Pfizer seems to have taken a particular liking to stem cells, having established a unit to study them last year |
ifeminists
February 1, 2006
Wendy McElroy |
Questions to Ask Scientific Authority Stem cell research may be the most sensational and explosive scientific development of recent years. It also highlights the admonition, "Question Authority." |
Chemistry World
April 6, 2009
Rebecca Trager |
US funding boost - a threat to EU science? These developments have raised some concern about the possibility of a 'brain drain' from Europe to the US, as these falling barriers have quickly made the region a more appealing destination for researchers. |
Reason
February 2005
Ronald Bailey |
The U.N. vs. Cloning In September 2004 President Bush strongly endorsed a United Nations resolution, proposed by Costa Rica, for a global treaty that would completely ban both reproductive cloning (that is, cloning to produce a baby) and therapeutic cloning. |
The Motley Fool
October 12, 2010
Travis Hoium |
Geron Shares Popped: What You Need to Know Geron shares jumped 10% after the company announced that its first patient has enrolled in the company's stem cell clinical trial. |
HHMI Bulletin
Aug 2010
Lawrence Goldstein |
Hear from the author of "Stem Cells for Dummies" The author, an investigator at the University of California, San Diego, is reaching out beyond policymakers in an unorthodox way. He's co-written Stem Cells for Dummies. |
The Motley Fool
June 21, 2005
Brian Gorman |
Stem Cell Chatter Despite the promise suggested by early studies, embryonic stem cell research remains highly speculative. More concrete results, not the amount of cash being poured into research, are the best basis for investing decisions. |
Salon.com
August 21, 2000
Lori B. Andrews |
Embryos under the knife The latest reproductive technology is just the next step on our sprint toward human cloning. |
Scientific American
December 2008
Tim Hornyak |
Turning Back the Cellular Clock: A Farewell to Embryonic Stem Cells? Shinya Yamanaka discovered how to revert adult cells to an embryonic state. These induced pluripotent stem cells might soon supplant their embryonic cousins in therapeutic promise |
Salon.com
June 18, 2002
Scott Anderson |
Playing God Bush's bioethics czar Leon Kass wants to criminalize lifesaving medical research as violating the natural order of things. Would he have opposed wiping out smallpox? |
The Motley Fool
August 31, 2007
Brian Orelli |
A Stem-Cell Primer Public funding from states could help companies doing stem cell research. Read about Geron, StemCells, Osiris Therapeutics, ViaCell and Invitrogen, companies that may profit from the increased public spending. |
HHMI Bulletin
February 2011
Sarah C.P. Williams |
Releasing the Brakes on Cell Fate Converting one cell type directly into another is a kind of modern-day alchemy, an ultimate goal in biological research. But unlike turning base metals into gold, changing a cell's identity is feasible, new research shows. |
Scientific American
May 2009
Choi & Wilcox |
Updates: Whatever Happened to the Universal Flu Vaccine? Fighting influenza... Mass extinctions... Stem cell ban... The right to sue drug companies... |
The Motley Fool
November 9, 2004
Charly Travers |
Are Stem Cells a Rule Breaker? Does the science offer real hope or just hype? Biotech investors take on enough risk in the normal course of drug development that they do not need to worry about whether or not the underlying technology even works. |
BusinessWeek
September 23, 2010
Rob Waters |
Stem Cells That Save Big Pharma a Bundle Drugmakers hope to save big by using stem cells to test drugs for dangerous side effects long before costly human trials are needed. |
The Motley Fool
July 26, 2004
Brian Gorman |
Stem Cell Researcher a Risk Geron could benefit from a new U.S. president, but in the end, studies of embryonic stem cells may or may not yield breakthroughs, so buying their stock now would be a gamble. |
Popular Mechanics
November 27, 2007
Alex Hutchinson |
Stem Cells 2.0: Beyond the Hype, Engineers Look to Build Fast Engineers play the important role of making lab bench discoveries reproducible and efficient for use in industry. |
Chemistry World
February 23, 2015
Phillip Broadwith |
Europe approves stem cell therapy A stem cell treatment for severe cornea damage has been granted conditional approval by the European commission. |
| Knowledge@Wharton |
Bettering Ourselves Through Biotech: Greater Productivity, Sharper Memories, Hair Feathers Beefing up muscle without steroids or hormones; rejuvenating damaged skin and heart tissue; ratcheting up memory function. Therapies that promise to enhance human abilities are nearing the marketplace. Funding, however, is hard to come by these days. |
The Motley Fool
November 28, 2007
Brian Orelli |
Stem Your Expectations of Stem-Cell Discoveries Making "stem" cells out of skin cells isn't all it's cracked up to be. The recent discovery has a long way to go before it can catch up to the research currently being done with stem cells. |
BusinessWeek
January 16, 2006
Arlene Weintraub |
What's Ethical And What Isn't? The debate over using human cells in animals for medical research. |
Chemistry World
April 2010 |
Column: The crucible We are getting better at manipulating cells to grow into the tissues we need. Chemical factors are key, says Philip Ball |
Wired
January 2001
Brian Alexander |
(You)2 Human cloning has always been frightening, seductive - and completely out of reach. Not anymore... |
Bio-IT World
July 15, 2003
Kevin Davies |
Stem Cell Suicide The International Society for Stem Cell Research must engage in a political discourse to salvage the hope of embryonic stem cell research. |
Scientific American
March 2007
Alison Snyder |
Sight for Sore Eyes Having generated a cell source and overcome the safety concerns associated with transplanting stem cells, researchers still face possibly their biggest challenge: showing that the transplanted photoreceptors wire up to other neurons that eventually connect to the optic nerves. |
HHMI Bulletin
May 2010
Sarah C.P. Williams |
Young Again Niche cells can reverse the aging of stem cells. |
Chemistry World
August 15, 2007
John Bonner |
Chemists Claim Biological Alchemy South Korean chemists say they have turned muscle cells from the sole of a human foot into something akin to stem cells, using a simple molecule called neurodazine. |
